Miranda Burdiel
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Unveiling miR-451a and miR-142-3p as prognostic markers in non-small cell lung cancer via small extracellular vesicle liquid biopsy.
Journal: Clinical and translational medicine
Published: December 16, 2025
Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.
Journal: Scientific reports
Published: January 08, 2024
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients.
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients.
Journal: International journal of molecular sciences
Published: May 30, 2023
Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy.
Journal: International journal of molecular sciences
Published: April 28, 2023
CDH6-activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers.
Journal: Molecular oncology
Published: September 14, 2020
Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients.
Journal: Archivos de bronconeumologia
Published: August 28, 2019
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 21, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026